65 i b, drugs, pharmaceuticals,&hematology related products, FSS contract award

Active Awarded Last action

Contract number
36F79719D0216
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • 65IB Solicitation number
Last date to order 90% complete
IDV ceiling
$9,023,351.75
Award type
Multiple award
Who can order
All agencies
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Veterans Affairs, administering the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), awarded a Multiple Award Schedule contract to Coherus Oncology, Inc. on August 15, 2019, with an ultimate completion date of August 14, 2027 and an evergreen option to extend.

The contract is approved under VA Schedule 65 I B for drugs, pharmaceuticals, and hematology-related products with a ceiling value of $9,023,351.75. No set-aside category applies. Place of performance is nationwide through the schedule's catalog-based pricing model, which permits ordering agencies to place orders against the contractor's price list without running new competitions. The contract carries a base performance period extending to August 14, 2027, with evergreen renewal language allowing continuation beyond that date.

Coherus Oncology offers oncology and specialty pharmaceutical products through this schedule vehicle, enabling federal customers — primarily Veterans Health Administration facilities and other federal health care systems — to procure drugs, pharmaceuticals, and hematology-related items from an established price list.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00038 · Evergreen option to extend $0
Other Administrative Action P00037 · POC change - contract administration, sales administration, and ordering contact $0
Supplemental Agreement for work within scope P00036 · 2026 public law pricing update $0
Supplemental Agreement for work within scope P00035 · Product deletion $0
Supplemental Agreement for work within scope P00034 · Temporary contract extension $0
Supplemental Agreement for work within scope P00033 · Product deletion $0
Supplemental Agreement for work within scope P00032 · Public law update 2025 $0
Supplemental Agreement for work within scope P00031 · Lifecycle change to permanent FCP $0
Supplemental Agreement for work within scope P00030 · Temporary contract extension $0
Supplemental Agreement for work within scope P00029 · Product deletion $0
Supplemental Agreement for work within scope P00028 · 65IB / (42-2A) / (tardy) lifecycle change / permanent stage / dual price / credits & rebills $0
Supplemental Agreement for work within scope P00027 · 65IB / (42-2A) / product addition / new package size at pro-rated (provisional) stage / single price $0
Supplemental Agreement for work within scope P00026 · 65IB / (42-2A) / (tardy) lifecycle change / temporary stage / dual price / authorization of credits & rebills $0
Supplemental Agreement for work within scope P00025 · 65IB / (42-2A) / (tardy) permanent price decrease (PPD) / BIG4 & OGA / authorization of credit & rebills $0
Supplemental Agreement for work within scope P00024 · 65IB / (42-2A) / (tardy) lifecycle change / permanent stage / credits & rebills / dual price $0
Supplemental Agreement for work within scope P00023 · Add-prov stage $0
Supplemental Agreement for work within scope P00022 · Add independent (perm) stage $0
Supplemental Agreement for work within scope P00021 · 2024 public law $0
Supplemental Agreement for work within scope P00020 · Lifecycle change $0
Supplemental Agreement for work within scope P00019 · Add-prov $0
Supplemental Agreement for work within scope P00016 · Lifecycle change (perm) $0
Other Administrative Action P00017 · Admin update: POC & SA $0
Supplemental Agreement for work within scope P00015 · TPD $0
Supplemental Agreement for work within scope P00013 · Lifecycle change $0
Supplemental Agreement for work within scope P00014 · TPD $0
Supplemental Agreement for work within scope P00012 · PL 2023 $0
Supplemental Agreement for work within scope P00011 · TPD $0
Supplemental Agreement for work within scope P00010 · Add $0
Supplemental Agreement for work within scope P00009 · PPD $0
Supplemental Agreement for work within scope P00008 · PL 2022 $0
Supplemental Agreement for work within scope P00007 · PPD $0
Other Administrative Action P00006 · SA $0
Supplemental Agreement for work within scope P00005 · PPD $0
Supplemental Agreement for work within scope P00004 · 2021 PL $0
Supplemental Agreement for work within scope P00003 · PPD $0
Supplemental Agreement for work within scope P00002 · PL 2020 $0
Supplemental Agreement for work within scope P00001 · Life cycle (temp to perm) $0
Original award $0
Show all 38

Quick answers

Who was awarded contract 36F79719D0216?

36F79719D0216 was awarded to Coherus Oncology, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on August 15, 2019.

How much is contract 36F79719D0216 worth?

36F79719D0216's own ceiling is $9,023,352.

Who can order from contract 36F79719D0216?

36F79719D0216 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79719D0216 part of a contract vehicle?

Yes. 36F79719D0216 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79719D0216 competed?

The extent of competition for 36F79719D0216 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV